Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial

Clinical trial NCT02971670 · COMPLETED

Trial details

NCT number: NCT02971670
Sponsor: Biomedizinische Forschungs gmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Toxic-Shock Syndrome Sepsis

Start date: 2015-10-01
Primary completion: 2016-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.